MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.78 Million CAD | 15.74% |
| 2022 | 4.99 Million CAD | 93.65% |
| 2021 | 2.58 Million CAD | 171.96% |
| 2020 | 948.92 Thousand CAD | 22.02% |
| 2019 | 777.67 Thousand CAD | 45.63% |
| 2018 | 534 Thousand CAD | -26.16% |
| 2017 | 723.14 Thousand CAD | -6.64% |
| 2016 | 774.54 Thousand CAD | -18.98% |
| 2015 | 956.01 Thousand CAD | 1110.14% |
| 2014 | 79 Thousand CAD | -61.27% |
| 2013 | 204 Thousand CAD | -78.54% |
| 2012 | 950.51 Thousand CAD | -4.74% |
| 2011 | 997.77 Thousand CAD | 26.57% |
| 2010 | 788.34 Thousand CAD | 1.15% |
| 2009 | 779.39 Thousand CAD | -7.06% |
| 2008 | 838.55 Thousand CAD | -68.13% |
| 2007 | 2.63 Million CAD | 244.26% |
| 2006 | 764.36 Thousand CAD | -52.31% |
| 2005 | 1.6 Million CAD | 31.1% |
| 2004 | 1.22 Million CAD | 441.5% |
| 2003 | 225.79 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 6.3 Million CAD | 8.97% |
| 2024 Q2 | 6.63 Million CAD | 5.34% |
| 2023 Q3 | 5.83 Million CAD | 1.59% |
| 2023 Q4 | 5.78 Million CAD | -0.81% |
| 2023 Q2 | 5.74 Million CAD | 10.06% |
| 2023 Q1 | 5.21 Million CAD | 4.38% |
| 2023 FY | 5.78 Million CAD | 15.74% |
| 2022 Q4 | 4.99 Million CAD | 28.34% |
| 2022 Q1 | 2.94 Million CAD | 14.23% |
| 2022 Q2 | 3.35 Million CAD | 13.77% |
| 2022 FY | 4.99 Million CAD | 93.65% |
| 2022 Q3 | 3.89 Million CAD | 16.12% |
| 2021 Q2 | 3.77 Million CAD | -0.69% |
| 2021 Q4 | 2.58 Million CAD | -28.21% |
| 2021 FY | 2.58 Million CAD | 171.96% |
| 2021 Q1 | 3.79 Million CAD | 300.2% |
| 2021 Q3 | 3.59 Million CAD | -4.69% |
| 2020 Q1 | 713.45 Thousand CAD | -8.26% |
| 2020 Q4 | 948.92 Thousand CAD | 75.73% |
| 2020 FY | 948.92 Thousand CAD | 22.02% |
| 2020 Q2 | 547.01 Thousand CAD | -23.33% |
| 2020 Q3 | 540 Thousand CAD | -1.28% |
| 2019 Q4 | 777.67 Thousand CAD | 10.74% |
| 2019 FY | 777.67 Thousand CAD | 45.63% |
| 2019 Q3 | 702.27 Thousand CAD | 2.64% |
| 2019 Q2 | 684.18 Thousand CAD | 13.76% |
| 2019 Q1 | 601.43 Thousand CAD | 12.63% |
| 2018 FY | 534 Thousand CAD | -26.16% |
| 2018 Q2 | 404.35 Thousand CAD | -11.08% |
| 2018 Q1 | 454.72 Thousand CAD | -37.12% |
| 2018 Q3 | 468.91 Thousand CAD | 15.97% |
| 2018 Q4 | 534 Thousand CAD | 13.88% |
| 2017 FY | 723.14 Thousand CAD | -6.64% |
| 2017 Q1 | 882.27 Thousand CAD | 13.91% |
| 2017 Q2 | 785.56 Thousand CAD | -10.96% |
| 2017 Q4 | 723.14 Thousand CAD | -5.28% |
| 2017 Q3 | 763.43 Thousand CAD | -2.82% |
| 2016 FY | 774.54 Thousand CAD | -18.98% |
| 2016 Q4 | 774.54 Thousand CAD | -17.8% |
| 2016 Q3 | 942.22 Thousand CAD | 0.24% |
| 2016 Q1 | 962.95 Thousand CAD | 0.73% |
| 2016 Q2 | 939.96 Thousand CAD | -2.39% |
| 2015 Q4 | 956.01 Thousand CAD | 40.8% |
| 2015 Q3 | 679 Thousand CAD | 0.0% |
| 2015 Q2 | 679 Thousand CAD | 279.33% |
| 2015 Q1 | 179 Thousand CAD | 126.58% |
| 2015 FY | 956.01 Thousand CAD | 1110.14% |
| 2014 FY | 79 Thousand CAD | -61.27% |
| 2014 Q3 | 79 Thousand CAD | 172.41% |
| 2014 Q4 | 79 Thousand CAD | 0.0% |
| 2014 Q2 | 29 Thousand CAD | -85.78% |
| 2014 Q1 | 204 Thousand CAD | 0.0% |
| 2013 Q3 | 878.77 Thousand CAD | -20.6% |
| 2013 Q2 | 1.1 Million CAD | 16.06% |
| 2013 Q1 | 953.65 Thousand CAD | 0.33% |
| 2013 Q4 | 204 Thousand CAD | -76.79% |
| 2013 FY | 204 Thousand CAD | -78.54% |
| 2012 Q2 | 1.02 Million CAD | 2.63% |
| 2012 Q3 | 316.13 Thousand CAD | -69.22% |
| 2012 Q4 | 950.51 Thousand CAD | 200.67% |
| 2012 FY | 950.51 Thousand CAD | -4.74% |
| 2012 Q1 | 1 Million CAD | 0.32% |
| 2011 Q3 | 945.19 Thousand CAD | 6.9% |
| 2011 FY | 997.77 Thousand CAD | 26.57% |
| 2011 Q4 | 997.77 Thousand CAD | 5.56% |
| 2011 Q2 | 884.22 Thousand CAD | 12.34% |
| 2011 Q1 | 787.08 Thousand CAD | -0.16% |
| 2010 Q2 | 779.39 Thousand CAD | -1.89% |
| 2010 Q4 | 788.34 Thousand CAD | 1.15% |
| 2010 FY | 788.34 Thousand CAD | 1.15% |
| 2010 Q3 | 779.39 Thousand CAD | 0.0% |
| 2010 Q1 | 794.42 Thousand CAD | 1.93% |
| 2009 Q3 | 784.4 Thousand CAD | -0.15% |
| 2009 Q4 | 779.39 Thousand CAD | -0.64% |
| 2009 Q1 | 794.94 Thousand CAD | -5.2% |
| 2009 FY | 779.39 Thousand CAD | -7.06% |
| 2009 Q2 | 785.59 Thousand CAD | -1.18% |
| 2008 Q1 | 1.05 Million CAD | -59.94% |
| 2008 Q2 | 1.05 Million CAD | -0.31% |
| 2008 FY | 838.55 Thousand CAD | -68.13% |
| 2008 Q3 | 546.12 Thousand CAD | -48.03% |
| 2008 Q4 | 838.55 Thousand CAD | 53.55% |
| 2007 Q1 | 1.24 Million CAD | 63.07% |
| 2007 Q2 | 2.2 Million CAD | 76.74% |
| 2007 Q3 | 2.37 Million CAD | 7.85% |
| 2007 Q4 | 2.63 Million CAD | 10.75% |
| 2007 FY | 2.63 Million CAD | 244.26% |
| 2006 Q3 | 1.81 Million CAD | 14.98% |
| 2006 Q4 | 764.36 Thousand CAD | -57.83% |
| 2006 Q2 | 1.57 Million CAD | 4.2% |
| 2006 Q1 | 1.51 Million CAD | -5.61% |
| 2006 FY | 764.36 Thousand CAD | -52.31% |
| 2005 Q2 | 696.44 Thousand CAD | 22.78% |
| 2005 Q4 | 1.6 Million CAD | 20.34% |
| 2005 Q3 | 1.33 Million CAD | 91.26% |
| 2005 Q1 | 567.22 Thousand CAD | -53.61% |
| 2005 FY | 1.6 Million CAD | 31.1% |
| 2004 Q4 | 1.22 Million CAD | 0.0% |
| 2004 FY | 1.22 Million CAD | 441.5% |
| 2003 FY | 225.79 Thousand CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 60 Thousand USD | -9540.46% |
| Össur hf. | 467.73 Million USD | 98.763% |
| QHSLab, Inc. | 1.78 Million USD | -224.676% |
| Wellstar International, Inc. | 51.36 Million USD | 88.739% |
| Össur hf. | 467.73 Million USD | 98.763% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -1002.357% |
| Aurora Spine Corporation | 2.67 Million USD | -116.594% |
| BrainsWay Ltd. | 471 Thousand USD | -1128.084% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1186.873% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 79.201% |
| BioElectronics Corporation | 14.83 Million USD | 60.999% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -1065.247% |
| Zecotek Photonics Inc. | 3.22 Million USD | -79.532% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -3147.513% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -10.852% |
| Avitar, Inc. | 5.26 Million USD | -9.858% |
| Nanomix Corporation | 11.4 Million USD | 49.289% |
| Theraclion SA | 1.95 Million EUR | -196.518% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | -43.105% |
| NewCardio, Inc. | 3 Million USD | -92.809% |
| Positron Corporation | 1.78 Million USD | -223.59% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -240.543% |
| Lombard Medical, Inc. | 32.29 Million USD | 82.088% |
| ALR Technologies Inc. | 19.26 Million USD | 69.974% |
| Stratec SE | 156.16 Million USD | 96.296% |
| Vycor Medical, Inc. | 1.11 Million USD | -420.99% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -2663.827% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -5684.276% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.659% |
| VMS Rehab Systems, Inc. | 133.52 USD | -4332042.001% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -181.063% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -816.456% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -763.325% |
| Odyssey Group International, Inc. | 2.14 Million USD | -169.706% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 81.892% |
| IR-Med Inc. | 161 Thousand USD | -3492.718% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -2898.681% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Polarean Imaging plc | 216.38 Thousand USD | -2573.141% |
| ECGI Holdings, Inc. | 3.17 Million USD | -82.397% |
| Capital Group Holdings, Inc. | 4944.00 USD | -116895.874% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -623.343% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -2448.117% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -50.999% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -37.224% |
| SS Innovations International, Inc. | 8.21 Million USD | 29.618% |
| Urologix, Inc. | 5.33 Million USD | -8.462% |
| Qualis Innovations, Inc. | 9102.00 USD | -63449.506% |
| Smith & Nephew plc | 3.07 Billion USD | 99.812% |
| NIOX Group Plc | 1.4 Million USD | -313.074% |
| Fuse Medical, Inc. | 1.99 Million USD | -190.133% |
| Broncus Holding Corporation | 2.35 Million USD | -145.684% |
| Brain Scientific Inc. | 2.86 Million USD | -102.001% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 74.584% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -14202.646% |